EMEA-000196-PIP01-08-M04
Key facts
Invented name |
Incivo
|
Active substance |
telaprevir
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0093/2017
|
PIP number |
EMEA-000196-PIP01-08-M04
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of chronic hepatitis C
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Janssen-Cilag International NV
E-mail: contact@janssen-emea.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|